Discovery of Potent Selective Nonzinc Binding Autotaxin Inhibitor BIO-32546.

Bin Ma, Lei Zhang, Lihong Sun, Zhili Xin, Gnanasambandam Kumaravel, Douglas Marcotte, Jayanth V Chodaparambil, Qin Wang, Angela Wehr, Jing Jing, Victor Sukbong Hong, Ti Wang, Carol Huang, Zhaohui Shao, Sha Mi
Author Information
  1. Bin Ma: Medicinal Chemistry, Physical Biochemistry, Drug Metabolism & Pharmacokinetics, Discovery Bioassay, Neurology, Biogen Inc., 225 Binney St, Cambridge, Massachusetts 02142, United States. ORCID
  2. Lei Zhang: Medicinal Chemistry, Physical Biochemistry, Drug Metabolism & Pharmacokinetics, Discovery Bioassay, Neurology, Biogen Inc., 225 Binney St, Cambridge, Massachusetts 02142, United States.
  3. Lihong Sun: Medicinal Chemistry, Physical Biochemistry, Drug Metabolism & Pharmacokinetics, Discovery Bioassay, Neurology, Biogen Inc., 225 Binney St, Cambridge, Massachusetts 02142, United States.
  4. Zhili Xin: Medicinal Chemistry, Physical Biochemistry, Drug Metabolism & Pharmacokinetics, Discovery Bioassay, Neurology, Biogen Inc., 225 Binney St, Cambridge, Massachusetts 02142, United States.
  5. Gnanasambandam Kumaravel: Medicinal Chemistry, Physical Biochemistry, Drug Metabolism & Pharmacokinetics, Discovery Bioassay, Neurology, Biogen Inc., 225 Binney St, Cambridge, Massachusetts 02142, United States.
  6. Douglas Marcotte: Medicinal Chemistry, Physical Biochemistry, Drug Metabolism & Pharmacokinetics, Discovery Bioassay, Neurology, Biogen Inc., 225 Binney St, Cambridge, Massachusetts 02142, United States.
  7. Jayanth V Chodaparambil: Medicinal Chemistry, Physical Biochemistry, Drug Metabolism & Pharmacokinetics, Discovery Bioassay, Neurology, Biogen Inc., 225 Binney St, Cambridge, Massachusetts 02142, United States.
  8. Qin Wang: Medicinal Chemistry, Physical Biochemistry, Drug Metabolism & Pharmacokinetics, Discovery Bioassay, Neurology, Biogen Inc., 225 Binney St, Cambridge, Massachusetts 02142, United States.
  9. Angela Wehr: Medicinal Chemistry, Physical Biochemistry, Drug Metabolism & Pharmacokinetics, Discovery Bioassay, Neurology, Biogen Inc., 225 Binney St, Cambridge, Massachusetts 02142, United States.
  10. Jing Jing: Medicinal Chemistry, Physical Biochemistry, Drug Metabolism & Pharmacokinetics, Discovery Bioassay, Neurology, Biogen Inc., 225 Binney St, Cambridge, Massachusetts 02142, United States.
  11. Victor Sukbong Hong: Medicinal Chemistry, Physical Biochemistry, Drug Metabolism & Pharmacokinetics, Discovery Bioassay, Neurology, Biogen Inc., 225 Binney St, Cambridge, Massachusetts 02142, United States.
  12. Ti Wang: Medicinal Chemistry, Physical Biochemistry, Drug Metabolism & Pharmacokinetics, Discovery Bioassay, Neurology, Biogen Inc., 225 Binney St, Cambridge, Massachusetts 02142, United States.
  13. Carol Huang: Medicinal Chemistry, Physical Biochemistry, Drug Metabolism & Pharmacokinetics, Discovery Bioassay, Neurology, Biogen Inc., 225 Binney St, Cambridge, Massachusetts 02142, United States.
  14. Zhaohui Shao: Medicinal Chemistry, Physical Biochemistry, Drug Metabolism & Pharmacokinetics, Discovery Bioassay, Neurology, Biogen Inc., 225 Binney St, Cambridge, Massachusetts 02142, United States.
  15. Sha Mi: Medicinal Chemistry, Physical Biochemistry, Drug Metabolism & Pharmacokinetics, Discovery Bioassay, Neurology, Biogen Inc., 225 Binney St, Cambridge, Massachusetts 02142, United States.

Abstract

Autotaxin (ATX) is a lysophospholipase D that is the main enzyme responsible for generating LPA in body fluids. Although ATX was isolated from a conditioned medium of melanoma cells, later it was discovered to play a critical role in vascular and neuronal development. ATX has also been implicated in primary brain tumor, fibrosis, and rheumatoid arthritis, as well as neurological diseases such as multiple sclerosis, Alzheimer's disease, and neuropathic pain. As ATX and LPA levels are increased upon neuronal injury, a selective ATX inhibitor could provide a new approach to treat neuropathic pain. Herein we describe the discovery of a novel series of nonzinc binding reversible ATX inhibitors, particularly a potent, selective, orally bioavailable, brain-penetrable tool compound BIO-32546, as well as its synthesis, X-ray cocrystal structure, pharmacokinetics, and in vivo efficacy.

References

  1. Biochim Biophys Acta. 2013 Jan;1831(1):86-92 [PMID: 22809994]
  2. ACS Med Chem Lett. 2020 May 14;11(6):1335-1341 [PMID: 32551021]
  3. Adv Drug Deliv Rev. 2001 Mar 1;46(1-3):3-26 [PMID: 11259830]
  4. Dev Biol. 2010 Mar 15;339(2):451-64 [PMID: 20079728]
  5. Curr Opin Investig Drugs. 2010 May;11(5):515-26 [PMID: 20419597]
  6. Cell Cycle. 2009 Nov 15;8(22):3695-701 [PMID: 19855166]
  7. Angiogenesis. 2008;11(3):301-10 [PMID: 18504643]
  8. Trends Biochem Sci. 2005 Oct;30(10):542-50 [PMID: 16125936]
  9. J Med Chem. 2015 Nov 12;58(21):8315-59 [PMID: 26200936]
  10. Bioessays. 2004 Aug;26(8):870-81 [PMID: 15273989]
  11. J Biol Chem. 2002 Oct 18;277(42):39436-42 [PMID: 12176993]
  12. Biol Cell. 2013 Aug;105(8):317-33 [PMID: 23611148]
  13. Sci Rep. 2021 Feb 17;11(1):3984 [PMID: 33597645]
  14. Expert Opin Ther Pat. 2017 Jul;27(7):815-829 [PMID: 28447479]
  15. Pain. 2000 Mar;85(1-2):301-3 [PMID: 10692633]
  16. ACS Med Chem Lett. 2016 Aug 02;7(9):857-61 [PMID: 27660691]
  17. Mol Cell Biol. 2006 Jul;26(13):5015-22 [PMID: 16782887]
  18. Bioorg Med Chem Lett. 2010 Apr 1;20(7):2264-9 [PMID: 20188554]
  19. J Biol Chem. 1992 Feb 5;267(4):2524-9 [PMID: 1733949]
  20. J Med Chem. 2016 Jun 23;59(12):5604-21 [PMID: 26745766]
  21. Nat Med. 2004 Jul;10(7):712-8 [PMID: 15195086]
  22. J Med Chem. 2011 Jul 14;54(13):4619-26 [PMID: 21615078]
  23. J Med Chem. 2017 May 11;60(9):3580-3590 [PMID: 28414242]
  24. Nat Med. 2008 Jan;14(1):45-54 [PMID: 18066075]
  25. Mol Pain. 2008 Feb 08;4:6 [PMID: 18261210]
  26. Nat Struct Mol Biol. 2011 Feb;18(2):205-12 [PMID: 21240269]
  27. J Cell Biol. 2002 Jul 22;158(2):227-33 [PMID: 12119361]

Word Cloud

Created with Highcharts 10.0.0ATXAutotaxinLPAneuronalwellneuropathicpainselectiveBIO-32546lysophospholipaseDmainenzymeresponsiblegeneratingbodyfluidsAlthoughisolatedconditionedmediummelanomacellslaterdiscoveredplaycriticalrolevasculardevelopmentalsoimplicatedprimarybraintumorfibrosisrheumatoidarthritisneurologicaldiseasesmultiplesclerosisAlzheimer'sdiseaselevelsincreaseduponinjuryinhibitorprovidenewapproachtreatHereindescribediscoverynovelseriesnonzincbindingreversibleinhibitorsparticularlypotentorallybioavailablebrain-penetrabletoolcompoundsynthesisX-raycocrystalstructurepharmacokineticsvivoefficacyDiscoveryPotentSelectiveNonzincBindingInhibitor

Similar Articles

Cited By